🇺🇸 FDA
Patent

US 11136350

Method to produce an immunoglobulin preparation with improved yield

granted A61KA61K35/16A61K38/1709

Quick answer

US patent 11136350 (Method to produce an immunoglobulin preparation with improved yield) held by Takeda Pharmaceutical Company Limited expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K35/16, A61K38/1709, A61K39/39525, A61K47/183